EMA Greenlights Cancer Treatments, Vaccines And Re-Examines Leqembi’s Safety Profile

 
• By Vibha Sharma

The European Medicines Agency has recommended eight new products for EU-wide approval, including cancer treatments and vaccines, and Ok'd a new antiparasitic combination for use in non-EU markets. It is also reviewing new safety information on Leqembi.

Traffic lights with green turned on against evening mountains
Eight New Products Headed For EU-Wide Approval Following EMA Nod (Shutterstock)

More from EU CHMP

More from Geography